These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18753727)

  • 1. Combination therapy with amiodarone and enalapril in patients with paroxysmal atrial fibrillation prevents the development of structural atrial remodeling.
    Komatsu T; Ozawa M; Tachibana H; Sato Y; Orii M; Kunugida F; Nakamura M
    Int Heart J; 2008 Jul; 49(4):435-47. PubMed ID: 18753727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of amiodarone therapy for the prevention of recurrence of paroxysmal atrial fibrillation. Analysis based on patient characteristics.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Kunugita F; Nakamura M
    Int Heart J; 2011; 52(4):212-7. PubMed ID: 21828946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combined spironolactone-β-blocker ± enalapril treatment on occurrence of symptomatic atrial fibrillation episodes in patients with a history of paroxysmal atrial fibrillation (SPIR-AF study).
    Dabrowski R; Borowiec A; Smolis-Bak E; Kowalik I; Sosnowski C; Kraska A; Kazimierska B; Wozniak J; Zareba W; Szwed H
    Am J Cardiol; 2010 Dec; 106(11):1609-14. PubMed ID: 21094362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of upstream therapy using angiotensin-converting enzyme inhibitors and statins in combination with antiarrhythmic agents for the treatment of paroxysmal atrial fibrillation.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Kunugida F; Orii M; Nakamura M
    Int Heart J; 2009 Jul; 50(4):465-76. PubMed ID: 19609051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study.
    Ueng KC; Tsai TP; Yu WC; Tsai CF; Lin MC; Chan KC; Chen CY; Wu DJ; Lin CS; Chen SA
    Eur Heart J; 2003 Dec; 24(23):2090-8. PubMed ID: 14643269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the long-term preventive effect of combined treatment with antiarrhythmic drugs plus angiotensin-converting enzyme inhibitors and circadian variation in the onset of paroxysmal atrial fibrillation.
    Komatsu T; Tachibana H; Satoh Y; Ozawa M; Kunugida F; Nakamura M
    Int Heart J; 2010; 51(5):331-6. PubMed ID: 20966605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of upstream therapy with lipophilic or hydrophilic statins on antiarrhythmic drugs in patients with paroxysmal atrial fibrillation: comparison between atorvastatin and pravastatin.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Kunugita F; Nakamura M
    Int Heart J; 2011; 52(6):359-65. PubMed ID: 22188709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of amiodarone for preventing the recurrence of symptomatic paroxysmal and persistent atrial fibrillation after cardioversion.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Nakamura M; Okumura K
    Circ J; 2007 Jan; 71(1):46-51. PubMed ID: 17186977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term clinical efficacy of losartan or perindopril combination therapy with low-dose amiodarone in patients with paroxysmal atrial fibrillation].
    Yin YH; Liu ZC; Wu JJ; Dai Y; Su L; Lan XB; Ling ZY; Yang XY; Luo KL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):299-302. PubMed ID: 16776916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
    Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
    Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
    Yin Y; Dalal D; Liu Z; Wu J; Liu D; Lan X; Dai Y; Su L; Ling Z; She Q; Luo K; Woo K; Dong J
    Eur Heart J; 2006 Aug; 27(15):1841-6. PubMed ID: 16825288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between efficacy of antiarrhythmic drug therapy and structural remodeling in patients with paroxysmal atrial fibrillation].
    Komatsu T; Nakamura S; Suzuki O; Yomogida K; Horiuchi D; Okumura K
    J Cardiol; 2005 Dec; 46(6):229-36. PubMed ID: 16389742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone.
    Shinagawa K; Shiroshita-Takeshita A; Schram G; Nattel S
    Circulation; 2003 Mar; 107(10):1440-6. PubMed ID: 12642367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-dose amiodarone on atrial fibrillation or flutter in Japanese patients with heart failure.
    Shiga T; Wakaumi M; Imai T; Suzuki T; Hosaka F; Yamada Y; Matsuda N; Shoda M; Sugiura R; Hagiwara N; Kasanuki H
    Circ J; 2002 Jun; 66(6):600-4. PubMed ID: 12074281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of amiodarone on autonomic status and its efficacy in the treatment of different variants of paroxysmal atrial fibrillation].
    Shabalin AV; Shaposhnikova IuS; Guseva IA
    Kardiologiia; 2002; 42(8):25-9. PubMed ID: 12494090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial.
    Goette A; Schön N; Kirchhof P; Breithardt G; Fetsch T; Häusler KG; Klein HU; Steinbeck G; Wegscheider K; Meinertz T
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):43-51. PubMed ID: 22157519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamics of echocardiographic changes and the tactic of optimal therapy in patients with atrial fibrillation with chronical heart failure].
    Abuladze GV; Dzhindzholiia NA; Dzhashi IA; Narsiia EV; Gudzhedzhiani LA
    Georgian Med News; 2007 Apr; (145):42-5. PubMed ID: 17525498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
    Singh BN; Mody FV; Lopez B; Sarma JS
    Am J Cardiol; 1999 Nov; 84(9A):161R-173R. PubMed ID: 10568677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation.
    Cybulski J; Kułakowski P; Budaj A; Danielewicz H; Maciejewicz J; Kawka-Urbanek T; Ceremuzyński L
    Clin Cardiol; 2003 Jul; 26(7):329-35. PubMed ID: 12862299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.